Arkolith/Insider Trading/ENZ/Form 4

Erfanian Hamid

Chief Executive OfficerENZO BIOCHEM INC (ENZ) · full profile →Form 4 · filed Apr 14, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 13, 2022Grant(A)10K$2.90$29K270K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 8, 2021Grant(A)700K—$0700K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-019771) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML